New pan-coronavirus vaccine passes key experiments, demonstrates protection
In laboratory and primate tests, a new pan-coronavirus vaccine developed by the Duke Human Vaccine Institute (DHVI) has demonstrated wide protection against SARS-CoV-2 viruses and variants, including omicron BA.5.
Oct 28, 2022
0
128